Form 4 for BIAF bioAffinity Technologies, Inc.

Accepted 2024-01-24 00:00:00 ET · period of report 2023-10-01 · accession 0001493152-24-003697 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2024-01-24	2023-10-01+	BIAF	Joyce Living Trust	CO-TRUSTEE	A - Grant	$1.53	+24.5K	24.5K	New	+$37.5K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-10-01	A	A	11,867	$1.58	11,867	D	—	—	(F1) Represents a grant from the Issuer to Dr. Joyce of 11,867 restricted shares of Common Stock, on October 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year
2	Common	Common Stock	2024-01-01	A	A	12,668	$1.48	24,535	D	—	—	(F2) Represents a grant from the Issuer to Dr. Joyce of 12,668 restricted shares of Common Stock, on January 1, 2024 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year.